Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » The High Costs of Measles Investigations

    The High Costs of Measles Investigations

    Two cases lead to massive follow-up in Denver

    January 1, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Identifying Characteristics of Children With High Hospital Costs

    Measles From Coast to Coast: Risks, Costs, and Potential Interventions

    After the midterm elections, Congress faces the uninsured and high costs

    Related Products

    Reports from the Field: Follow-up care reduces costs in high-risk infants | Single Article

    Patient has high out-of-pocket costs? Find out earlier! Move financial talk to front end | Single Article

    High rate of office visits and cumulative costs prior to colonoscopies for colon cancer screening

    Adding to the frustration of the re-emergence of measles — a childhood vaccine-preventable disease — are the labor-intensive high cost investigations to track down all people exposed to a case that was not immediately identified and isolated.

    How expensive? Two unrelated cases that occurred from July 2016 to January 2017 in Denver required public health expenditures in excess of $68,000, the CDC reported.

    The costs spiraled because each case exposed hundreds of people, triggering a response by multiple public health agencies. Both patients had traveled to countries with endemic measles transmission.

    “Increased awareness of the risk of travel-associated measles infection is needed,” the CDC recommended. “Prior to international travel, measles-mumps-rubella vaccination is recommended to prevent measles disease.”

    No secondary cases of measles were identified in either investigation, the CDC reported. The first case required post-exposure prophylaxis (PEP) to 31 contacts, but no PEP was administered in the second case because of a delay in diagnosing measles.

    “Public health costs of disease investigation in the first and second case were estimated at $49,769 and $18,423, respectively,” the CDC concluded. “Single measles cases prompted coordinated public health action and were costly and resource-intensive for local public health agencies.”

    The first case was a 14-month-old infant diagnosed with measles who potentially exposed people in a number of settings, including three healthcare facilities, an apartment building, and a children’s math and reading center. The second unrelated measles case was an unvaccinated man who had traveled to Thailand. The man eventually was hospitalized, but during the infectious period he visited 17 businesses and two healthcare facilities. In total, the cases required follow-up on hundreds of people. The first case required 756 hours of public health labor, and the second 435 hours.

    “Failure of clinicians to recognize measles early in the course of illness in these two cases serves as a reminder that healthcare providers might not be familiar with clinical measles or aware of the risk for measles transmission during international travel,” the CDC stated. “Healthcare providers need to recommend MMR vaccination before travel when appropriate and maintain a high index of suspicion for measles in patients with a febrile rash illness, particularly unvaccinated returning international travelers.”

    REFERENCE

    1. CDC. Public Health Economic Burden Associated with Two Single Measles Case Investigations — Colorado, 2016–2017. MMWR 2017;66(46):1272–1275.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Hospital Infection Control & Prevention

    View PDF
    Hospital Infection Control & Prevention (Vol. 45, No. 1) January 2018
    January 1, 2018

    Table Of Contents

    Quest for a Universal Flu Shot Ramps Up at NIH

    HIV Update: Testing Urged to Continue Progress

    Bad Bugs in Small Hospitals

    Stewardship Recommendations for Critical Access Hospitals

    CMS Reg in Limbo, but Joint Commission Standard Kicks In

    Joint Commission Antibiotic Stewardship Standard

    Flu Vaccine Refusal: 50 Healthcare Workers Fired

    The High Costs of Measles Investigations

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Senior Writer Gary Evans, Editor Jesse Saffron, Editor Jill Drachenberg, Nurse Planner Patti Grant, RN, BSN, MS, CIC, Peer Reviewer Patrick Joseph, MD, and Editorial Group Manager Terrey L. Hatcher report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2021 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing